Saphnelo
Brand Name: Saphnelo
Generic Name: Anifrolumab
Active
Registration Number
BR-1466
Dosage Form
Concentrate for Solution for Infusion (IV)
Issuance Date
February 14, 2024
Expiry Date
February 14, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength300 mg/2 mL (150 mg/ml)
Packaging2 mL net content Type I clear and colorless glass vial, sealed with tefloncoated chlorobutyl elastomer stopper. and secured by aluminium seal with flip-off plastic button (Box of 1 vial)
.
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Monoclonal Antibody.
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
AnifrolumabActive
Monograph: Anifrolumab